Biogazelle
Zwijnaarde
About Biogazelle
Biogazelle offers expert laboratory services in nucleic acid quantification (gene expression, mutation, and copy number analysis, antisense oligonucleotide screening) to support its customers in their development of diagnostics and therapeutics. Customized workflows for clinically relevant samples – from liquid biopsies to fixed tissues – are available. In addition, Biogazelle’s advanced RNA biomarker development program offers an end-to-end solution from RNA biomarker panel discovery (including liquid biopsies) to the development of a PCR-based molecular diagnostic test. Biogazelle also serves as a specialty lab in the field of clinical trials and in routine diagnostic settings.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2014)
- Website: biogazelle.com
- Phone: +32 9 241 56 08
Industries & Categories
Biotechnology, Genetics, Medical
Social Profiles
Canonical: https://fsome.com/organization/biogazelle-3222607 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.